Categories
Category: Customer stories
Optimizing production workflows with the BioXp™ system
We caught up with Jason Lehmann, Senior Product Marketing Manager at Codex DNA, as he shares how our synthetic biology workstation, the BioXp™ system, can accelerate your time to results by optimizing production workflows and overcoming synthesis bottlenecks. How do…
In our DNA: Ken Williams, Bioinformatics Scientist Lead
We’re continuing our blog series, looking at the DNA of Codex DNA — our incredible employees and their stories. Team member: Ken Williams, Bioinformatics Scientist Lead Came aboard: February 2020 What do you do at Codex DNA? I develop the…
Empowering Scientists to Make Breakthrough Discoveries to Address Humanity’s Greatest Challenges
Codex DNA’s mission is to drive innovation and apply breakthroughs in automation solutions for DNA, mRNA, and protein synthesis. These tools enable scientists to “write” biology for the betterment of the world, creating sustainable healthcare and technology solutions for humanity’s…
PEGS Europe 2021: The Recap
The Codex DNA team recently attended PEGS Europe, held this year in Barcelona, Spain. With over 200 speakers including 15 keynote addresses, the conference brings together scientific professionals to discuss the latest developments in protein and antibody engineering, cell and…
With mRNA Capping Technology, We’re Improving Synthesis Yields
If you’re working with synthetic mRNA, we have exciting news to share. In addition to releasing a new workflow earlier this year that makes it possible to synthesize mRNA form pooled oligos in a single overnight run on our BioXp™…
Unlock the potential of BioXp™ automation solutions for bio-fuel production
Our BioXp™ automated end-to-end benchtop system has been used by scientists in many different focus areas to advance breakthroughs in protein engineering. We are delighted to share a great example of utilizing BioXp gene and clone workflows to build recombinant…
Case study: How Cellibre transformed enzyme engineering with Codex DNA
In San Diego, scientists at ag biotech startup Cellibre are looking to replace traditional agriculture for producing high-value ingredients. One of their first targets is the highly valuable cannabinoid market, which they believe can be disrupted by producing natural, high-quality,…
Scientists use automated DNA synthesis to identify response to antimicrobial threats
Scientists use automated DNA synthesis to identify regulatory mechanism in E. coli response to antimicrobial threats. Bacterial resistance to antibiotics is a looming public health crisis, and scientists continue to investigate how to better characterize the molecular mechanisms underpinning this…
Countering emerging SARS-CoV-2 variants webinar recap: Four key takeaways
Last week, we had the opportunity to partner with Jesse Erasmus, Acting Assistant Professor of the University of Washington School of Medicine and Director of Virology at HDT Bio, presenting a webinar titled Development of a replicon RNA vaccine platform…
Codex DNA presents webinar: Countering emerging SARS-CoV-2 variants with Dr. Jesse Erasmus
The global COVID-19 pandemic caused by the novel SARS-CoV-2 coronavirus created an urgent need for protective interventions. Fortunately, new advances in vaccine development — including nucleic acid-based approaches — have enabled the unprecedented rollout of multiple vaccine products within a…
For HIV vaccine study, scientists build pooled variant library using automated DNA synthesis
The quest for an effective vaccine against HIV has spanned decades. While the vaccine itself remains elusive, researchers are making important strides in figuring out how best to design and develop it. Recently, scientists from Duke University and NIH’s Vaccine…